National Bank Of Canada Immunic, Inc. Transaction History
National Bank Of Canada
- $72.7 Billion
- Q3 2024
A detailed history of National Bank Of Canada transactions in Immunic, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 250 shares of IMUX stock, worth $247. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250
Previous 250
-0.0%
Holding current value
$247
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding IMUX
# of Institutions
71Shares Held
56.3MCall Options Held
100Put Options Held
350K-
Bvf Inc San Francisco, CA8.9MShares$8.81 Million0.47% of portfolio
-
Avidity Partners Management LP Dallas, TX8.27MShares$8.18 Million0.84% of portfolio
-
Soleus Capital Management, L.P. Greenwich, CT7.29MShares$7.22 Million1.02% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.59MShares$5.54 Million0.02% of portfolio
-
Janus Henderson Group PLC London, X05.1MShares$5.05 Million0.0% of portfolio
About IMMUNIC, INC.
- Ticker IMUX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,565,000
- Market Cap $30.3M
- Description
- Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...